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With	this	study,	we	aimed	to	improve	solubility	and	provide	enhanced	
evaluation	of	antimicrobial	activity	with	the	addition	of	glycerol	as	a	co‐solvent	with	
DMSO.		The	antimicrobial	activities	of	glycerol	and	DMSO	were	evaluated	against	
Staphylococcus	aureus,	and	glycerol	was	found	to	be	cause	less	growth	inhibition.	
Compounds	with	poor	water	solubility	were	selected	for	biological	screening	and	
solubility	testing.	The	glycerol/DMSO	solution	improved	the	time	to	solubilize	(at	
10mM)	in	ten	out	of	the	twenty‐one	tested	compounds.	Apparent	assay	solubility	
was	assessed	using	turbidity	measurements	with	a	spectrophotometer	at	600	nm.	
Notable	improvement	in	solubility	(where	less	light	was	blocked	by	lack	of	
particulate	matter)	was	observed	for	six	compounds	with	glycerol/DMSO	in	media.	
To	gauge	our	spectrophotometric	analysis	of	solubility,	we	subjected	six	compounds	
to	analysis	with	liquid‐chromatography	coupled	to	mass	spectrometry.		These	
analyses	confirmed	the	solubility	results	obtained	spectrophotometrically.	
Improved	bioactivity	with	glycerol/DMSO/media	against	S.	aureus	was	observed	for	
four	of	the	seven	active	compounds,	resulting	in	minimum	inhibitory	concentrations	
(MIC)	less	than	that	of	our	standard	water/DMSO/media	solution.	This	study	
provides	a	rapid	and	effective	way	of	assessing	solubility	in	standard	antimicrobial	
assay	conditions	and	offers	new	solutions	for	improving	solubility	in‐vitro	by	
employing	glycerol	as	a	co‐solvent.	
 
GLYCEROL	FOR	IMPROVING	SOLUBILITY	AND	EVALUATION	OF	ANTIMICROBIAL	
ACTIVITY	FOR	NATURAL	PRODUCTS	
	
by	
	
David	B.	Zich	
	
	
	
A	Thesis	Submitted	to	
the	Faculty	of	The	Graduate	School	at	
The	University	of	North	Carolina	at	Greensboro	
in	Partial	Fulfillment	
of	the	Requirements	for	the	Degree	
Master	of	Science	
	
	
	
	
	
	
Greensboro	
2016	
	
	
																																			Approved	by	
																																																																																							_________________________________________	
	 	 	 	 	 																			Committee	Chair
ii 
 
APPROVAL	PAGE	
	
	
	 This	thesis	written	by	David	B.	Zich	has	been	approved	by	the	following	committee	
of	the	Faculty	of	The	Graduate	School	at	The	University	of	North	Carolina	at	Greensboro	
	
	
	 Committee	Chair	 __________________________________________	
																																																																						Nadja	B.	Cech	
	
	 Committee	Members	 __________________________________________	 	
	 	 																			Nicholas	Oberlies	
	
	 	 __________________________________________	
	 	 	 												Ethan	Taylor	
	
	
	
	
_______________________________________	
Date	of	Acceptance	by	Committee	
	
___________________________________	
Date	of	Final	Oral	Examination	
iii 
 
ACKNOWLEDGEMENTS	
	
	
	 None	of	the	work	listed	here	would	have	been	possible	without	the	
continued	guidance,	support,	and	mentorship	of	Dr.	Nadja	Cech.		As	an	
undergraduate	here,	I	never	considered	the	possibility	of	going	to	graduate	school	
until	the	day	she	asked	me	to	apply	as	an	undergraduate	researcher	in	her	lab.	I	am	
forever	thankful	for	that	as	I	would	not	be	where	I	am	today	without	her.	
	 I	would	also	like	to	thank	Dr.	Daniel	Todd,	for	his	constant	advice	for	
troubleshooting	a	variety	of	issues	and	problems	during	my	four	year	stay	as	well	as	
always	providing	moral	support	when	things	didn’t	work	out	as	planned.		I	would	
like	to	thank	Nadjali	Chung,	for	her	assistance	with	a	lot	of	the	work	that	went	into	
this	project.	The	Cech	lab	as	a	whole,	for	being	my	second	family	and	for	always	
pushing	me	to	go	further	than	I	ever	expected.		The	faculty	and	staff	at	UNCG	for	
always	being	available	anytime	to	answer	any	questions	I	have;	in	particular,	Dr.	
Oberlies,	Dr.	Croatt,	and	Dr.	Taylor.		My	family,	in	particular	my	mother	Cynthia,	for	
always	standing	behind	me	no	matter	what	path	in	life	I	chose.	Finally,	I’d	like	to	
thank	the	National	Center	for	Complementary	and	Integrative	Health,	a	component	
of	the	National	Institutes	of	Health	for	supporting	me	financially	through	our	grant.	
	
	
	
	
	
iv 
 
TABLE	OF	CONTENTS	
	
Page	
	
LIST	OF	TABLES	..........................................................................................................................................	v	
	
LIST	OF	FIGURES	.......................................................................................................................................	vi	
	
CHAPTER	
	
	 I.		GLYCEROL	FOR	IMPROVING	SOLUBILITY	AND	EVALUATION	OF		
	 		ANTIMICROBIAL	ACTIVITY	FOR	NATURAL	PRODUCTS	................................	1	
	 	
	 II.	RESULTS	AND	DISCUSSION	..................................................................................................	5	
	
	 III.	EXPERIMENTAL	......................................................................................................................	22	
	
	 IV.	CONCLUSION	.............................................................................................................................	24	
	
REFERENCES	.............................................................................................................................................	25	
	
	
	
	
	
	
	
	
	
	
	
	
v 
 
LIST	OF	TABLES	
	
Page	
	
Table	2.1	Comprehensive	Solubility	Data	.....................................................................................	12	
	
Table	2.2	LC‐MS	Selected	Ion	Chromatogram	Peak	Area	Comparisons	with		
										Standard	Error	.................................................................................................................	19	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
vi 
 
LIST	OF	FIGURES	
Page	
	
Figure	2.1	Comparison	of	Growth	Inhibition	by	Glycerol	and	DMSO	.................................	6	
Figure	2.2	%DMSO	in	Varying	Concentrations	of	Glycerol	vs	S.	aureus	.............................	7	
Figure	2.3	Isobologram	of	Solvent	Combinations	.......................................................................	8	
Figure	2.4	Tested	Compounds	...........................................................................................................	10	
Figure	2.5	Comparison	of	Aurofusarin	in	Solvents	...................................................................	13	
Figure	2.6	Solubility	Analysis	of	Enoxolone	.................................................................................	14	
Figure	2.7	Solubility	Analysis	of	Quinalizarin	.............................................................................	15	
Figure	2.8	Quinalizarin	Absorbance	Spectrum	...........................................................................	16	
Figure	2.9	Enoxolone	Absorbance	Spectrum	...............................................................................	17	
Figure	2.10	LC‐MS	Selected	Ion	Chromatogram	of	Enoxolone	............................................	18	
Figure	2.11	Minimum	Inhibitory	Concentration	Studies	of	Enoxolone	...........................	20	
	
	
	
	
	
1 
 
CHAPTER	I	
	
GLYCEROL	FOR	IMPROVING	SOLUBILITY	AND	EVALUATION	OF	ANTIMICROBIAL		
ACTIVITY	FOR	NATURAL	PRODUCTS	
	
	
1.1	Introduction	
An	estimated	30%	of	all	potential	drug	leads	fail	due	to	some	type	of	
pharmacokinetic	issue,	with	solubility	(falling	under	the	absorption	category	of	
ADME)	often	being	the	hardest	to	overcome.1	These	solubility	issues	frequently	
present	themselves	early	in	bioassay	screenings,	where	assay	compositions	are	
often	limited	to	low	concentrations	of	dimethyl	sulfoxide	(DMSO)	in	media	to	
solubilize	the	target	compound	or	extract.2	DMSO	has	long	been	used	in	both	
academic	and	industrial	practices	for	its	ability	to	dissolve	a	diverse	array	of	organic	
and	inorganic	compounds.3	4	However,	its	decomposition	products	(water,	
formaldehyde,	methyl	mercaptan,	dimethyl	sulfide,	and	dimethyl	disulfide)	can	
prove	to	be	quite	harmful	in	bioassay	screenings	and	make	long	term	storage	of	
compounds	dissolved	in	this	solvent	problematic.3	Furthermore,	there	are	a	large	
number	of	compounds	which	are	poorly	soluble	in	DMSO	(a	common	solvent	for	
high	throughput	screening	assays)	that	could	potentially	have	interesting	biological	
activity.5	6	7	Frequently,	compounds	which	are	poorly	solubilized	by	DMSO	fall	into	
two	categories3:	1.	The	compound	is	composed	of	a	strong	crystalline	lattice	making	
it	hard	for	DMSO	to	penetrate	and	solubilize.	2.	The	compound	has	a	high	molecular	
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weight	(strong	intermolecular	forces,	typically	>500	MW),	a	high	number	of	
rotatable	bonds8	and	high	LogP	values	(a	partition	coefficient	between	octanol	and	
water),	of	which	violate	Lipinski’s	rule	of	5	for	potential	drug	canidates.2,	9These	
potential	downfalls	make	the	addition	of	a	co‐solvent	to	help	solubilize	
advantageous	in	biological	assays.	With	improved	solubility,	compounds	that	
previously	may	have	been	deemed	inactive	due	to	poor	solubility	might	show	new	
activity.	
One	potential	co‐solvent	that	could	be	used	to	improve	solubility	is	glycerol.	
Glycerol,	a	naturally	occurring	sugar	alcohol,	has	long	been	used	as	a	solvent	for	
preparing	dietary	supplements	because	of	its	sweet	flavor	and	low	toxicity.	Glycerol	
is	also	used	to	preserve	bacterial	and	mammalian	cells	prior	to	storage	at	low	
temperatures,	and	appears	to	be	well	tolerated	at	high	concentration.10	Despite	
these	appealing	attributes,	glycerol	is	rarely,	if	ever,	used	as	a	solvent	for	in	vitro	
biological	assays.	With	these	experiments,	we	set	out	to	explore	the	potential	
effectiveness	of	glycerol	as	a	solvent	for	improving	solubility	and	biological	activity	
of	antimicrobial	agents	in	vitro.		In	addition,	we	sought	to	develop	a	rapid	strategy	of	
identifying	situations	in	which	test	compounds	demonstrate	poor	solubility.	
We	chose	to	use	Staphylococcus	aureus	as	our	model	organism	for	bioassay	
screenings	due	to	its	medical	relevance.11	S.	aureus	is	one	of	the	leading	causes	of	
skin	infections	each	year,	infecting	80,000	people	and	killing	11,000	in	2011	alone,	
according	to	the	CDC.	In	evaluating	activity	against	S.	aureus,	we	expect	that	some	
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chemical	classes	will	demonstrate	poor	solubility	in	standard	assay	conditions,	and	
as	a	result	to	present	poor	minimum	inhibitory	concentration	(MIC)	values.	Our	
expectation	is	the	glycerol	will	improve	the	solubility	of	these	compounds,	resulting	
in	improved	biological	activity.	
Often	with	these	bioassay	screenings,	the	small	plates	and	well	sizes	can	
make	it	hard	to	visually	see	particulate.		Thus,	the	application	of	a	robust	analytical	
method	to	diagnose	solubility	issues	would	be	very	valuable	in	a	high	throughput	
screening	scenario.	The	two	standard	methods	of	determining	solubility	rely	either	
on	high	performance	liquid	chromatography	(HPLC)	or	spectrophotometry.12	HPLC	
offers	the	ability	to	distinguish	contaminates	and	degradation	products	that	
spectrophotometers	cannot,	but	at	the	cost	of	efficiency.12	Due	to	the	speed	at	which	
spectrophotometers	can	generate	data,	they	are	an	optimal	choice	for	high	
throughput	screenings.	Work	done	by	Chen	using	a	96‐well	plate	format	in	a	multi‐
wavelength	plate	reader	offered	a	rapid	method	of	determining	solubility	in	plates	
already	used	for	biological	testing,	but	still	required	filtering	of	the	plate	before	
reading	the	absorbance	values.13		
We	sought	out	a	slightly	different	approach	of	determining	solubility	using	
turbidimetric	studies	that	are	typically	done	in	nephelometry14,	but	in	a	96‐well	
format	with	a	plate	reader	concurrent	with	our	biological	assay	readings.	Lipinski	
has	shown	turbidimetric	approaches	using	wavelengths	at	600	nm	or	greater	can	be	
used	to	quickly	identify	compounds	with	poor	solubility,	though	his	methods	
4 
 
differed	by	looking	at	solubility	in	a	buffered	solution	using	a	dedicated	diode	array	
UV	detector.	9	Absorbance	at	a	wavelength	of	600	nm	is	already	widely	used	to	
monitor	bacterial	growth	in	antimicrobial	assays.15	We	propose	that	a	similar	
approach	(monitoring	absorbance	at	600	nm)	could	be	effective	for	evaluating	
compound	solubility.		Compounds	that	have	poor	solubility	(i.e	crashing	out)	should	
result	in	a	high	absorbance	due	to	light	scattering	by	undissolved	particles.		The	
experiments	described	herein	explore	the	application	of	absorbance	readings	in	a	
96	well	plate	format	as	a	means	to	diagnose	poor	solubility,	and	demonstrate	the	
effectiveness	of	this	approach	for	comparing	the	ability	of	various	solvent	
combinations	to	dissolve	biologically	active	natural	products.	
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CHAPTER	II	
	
RESULTS	AND	DISUCSSION	
	
	
2.1	Growth	Inhibition	by	DMSO	and	Glycerol	
As	a	first	step	in	these	studies,	a	comparison	was	made	between	the	effects	of	
DMSO	and	glycerol	on	growth	of	a	Staphylococcus	aureus	culture.		Figure	2.1	shows	a	
comparison	of	solvents	(DMSO	and	glycerol)	with	various	percentage	compositions	
in	broth	grown	with	Staphylococcus	aureus.	Overall,	the	inhibitory	effect	of	glycerol	
in	comparison	to	DMSO	was	found	to	be	much	lower	(Figure	2.1).	At	low	
concentrations	(<4%)	of	glycerol,	a	slight	increase	in	bacterial	growth	in	
comparison	to	the	vehicle	(broth	with	bacteria).		As	concentrations	of	glycerol	were	
increased	bacterial	growth	was	inhibited	and	at	32%,	glycerol	was	found	to	be	
completely	inhibitory.	By	contrast,	DMSO	was	found	to	be	inhibitory	at	levels	as	low	
as	1%,	and	completely	inhibitory	at	16%.	The	data	presented	in	Figure	2.1	confirm	
our	assumption	that	glycerol	is	much	less	antimicrobial	than	DMSO,	making	it	an	
appealing	co‐solvent.
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Figure	2.1	Comparison	of	Growth	Inhibition	by	Glycerol	and	DMSO.	A	
comparison	of	the	effects	of	DMSO	and	glycerol	on	growth	of	Staphylococcus	
aureus	in	broth.		The	vehicle	control	containing	neither	solvent	was	normalized	
to	100%	growth	and	subsequent	solvent	compositions	were	compared	to	this	
number.	Glycerol	caused	less	growth	inhibition	than	DMSO	making	it	an	ideal	
co‐solvent.		
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Figure	2.2	%DMSO	in	Varying	Concentrations	of	Glycerol	vs	S.	aureus.	
Combination	studies	of	glycerol	and	DMSO	at	varying	concentrations	versus	
S.	aureus.	As	DMSO	levels	in	glycerol	increased,	we	see	a	decrease	in	the	
growth	of	the	bacteria.		
	
	
Additional	experiments	were	conducted	to	evaluate	the	combined	effects	of	
glycerol	and	DMSO	on	growth	of	Staphylococcus	aureus	(Figure	2.2).	At	low	levels	of	
either	solvent	combined,	bacterial	growth	was	mostly	uninhibited.	At	combined	
concentrations	totaling	8%	(e.g.	2%	glycerol	with	6%	DMSO)	or	more,	a	decline	of	
growth	is	observed,	until	complete	inhibition	at	16%	or	more.	To	ensure	there	was	
no	synergistic	effect	of	the	solvents	against	the	bacteria,	an	isobologram	was	plotted	
as	shown	in	Figure	2.3.	
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Figure	2.3.	Isobologram	of	Solvent	Combinations.	An	isobologram	of	the	
combinatorial	studies	of	glycerol	and	DMSO	inhibition	of	S.	aureus.	
	
	
Isobolograms	are	frequently	used	to	determine	if	potential	drugs	(or	solvents	
in	this	case)	yield	greater	inhibition	of	the	bacteria	in	combination	than	their	
individual	effects	could	achieve.16	This	could	be	problematic	as	any	deviation	in	
assay	conditions	could	yield	results	not	indicative	of	bacterial	suppression	by	a	
compound	but	instead	of	the	solvents.		At	low	concentrations	of	glycerol,	high	
amounts	of	DMSO	were	required	to	completely	inhibit	the	bacteria,	as	indicated	by	
the	isobologram.	This	was	true	up	to	10%	glycerol	where	we	begin	to	see	a	linear	
decrease	in	the	amount	of	DMSO	required.	This	linear	trend	in	the	isobologram	
demonstrates	that	there	is	no	synergistic	effect	between	the	two	solvents	and	that	
their	influence	on	bacterial	growth	is	additive.16	Using	the	results	from	Figures	2.2	
and	2.3,	a	concentration	of	2%	DMSO	and	2%	glycerol	was	chosen	for	our	assay,	
which	is	a	standard	amount	of	DMSO	for	antimicrobial	studies.11,	17	To	compare	the	
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effectiveness	of	this	new	co‐solvent	composition	to	the	commonly	employed	broth	
composition,	we	chose	a	control	containing	2%	DMSO	with	2%	water.				
2.2	Solubility	Analysis	
A	series	of	compounds	representing	common	natural	products	were	chosen	
as	the	focus	of	these	studies	(Figure	2.4).		Primarily,	compounds	known	in	the	
literature	to	be	poorly	soluble18,	(1,	2,	4,	5,	12,	14,	15,	and	17)	were	chosen	with	the	
intention	of	evaluating	how	solubility	could	be	improved	with	the	addition	of	
glycerol	as	a	co‐solvent.		Additional	compounds	were	selected	to	reflect	common	
classes	of	natural	products	(3,	6,	7,	8,	9,	10,	11,	12,	13,	16,	18,	19,	20,	21).	We	aimed	
to	test	from	as	many	families	as	possible	to	ensure	our	method	of	detecting	
solubility	problems	was	more	conclusive	and	not	limited	to	one	set	of	compounds.	
The	experiments	described	in	the	next	sections	show	comparisons	of	various	
parameters	related	to	solubility	of	these	compounds	between	2%	DMSO/2%	
glycerol	and	2%DMSO/2%	water	(in	Müeller‐Hinton	broth).		
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Figure	2.4.	Tested	Compounds. kaempferol	(1) enoxolone	(2) naringenin	(3)	apigenin	(4)
luteolin	(5)	magnolol	(6)	berberine	(7)	myricetin	(8)	hesperetin	(9)	atropine	(10)	anisodamine	
(11)	reserpine	(12)	chrysin	(13)	Taxol	(14)	aurofusarin	(15)	pelargonidin	(16)	quinalizarin	(17)	
cornin	(18)	stigmasterol	(19)	simvastatin	(20)	α‐mangostin	(21)
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2.2.1.	Time	to	Solubilize	 	
To	begin	comparison	of	solubility,	we	chose	to	examine	the	length	of	time	it	
took	each	compound	to	solubilize	in	each	test	solution.	Time	to	dissolve	compounds	
prior	to	biological	assay	can	be	very	lengthy,	and	we	expected	that	the	
DMSO/glycerol	solution	might	speed	this	up	in	comparison	to	DMSO/water.		
Our	findings	in	Table	2.1	show	DMSO/glycerol	decreased	the	amount	of	time	
required	to	solubilize	10	out	of	the	21	standards		employed	here	by	>20	seconds.	
While	many	of	these	compounds	did	eventually	solubilize	in	the	DMSO/water	
solvent,	the	amount	of	time	and	effort	(heating,	sonicating,	vortexing)	was	usually	
less	with	the	glycerol/DMSO	solvent	composition.	It	was	also	noted	that	in	
compounds	with	poor	solubility	in	standard	preparation	(i.e.	time	to	solubilize	
>9minutes)	in	both	solvents	(12,	13,	15,	19),	the	glycerol	aided	in	dispersing	the	
compound	throughout	the	vial,	while	in	water/DMSO,	the	compounds	tended	to	
aggregate	in	clumps	(Figure	2.5).	
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Table	2.1	Comprehensive	Solubility	Data	
Structure	 Family	
MIC	in	
Glycerol
/DMSOA	
MIC	in	
Water/	
DMSOA	
Dissolving	
Time	
Glycerol/	
DMSO	
Dissolving	
Time	
Water/	
DMSO	
OD600	
Glycerol/	
DMSOA	
(400µM)	
OD600	
Water/	
DMSOA	
	(400µM)	
(1)  Flavonol  75 µM  75 µM  1.30 min  3.30 min 
0.273 ± 
0.019* 
0.204 ± 
0.012 
 (2)  Terpenoid  250 µM  >400 µM  52 sec  9+ min 
0.039 ± 
0.016* 
0.506 ± 
0.002 
(3)  Flavanone  >400 µM  >400 µM  46 sec  47 sec 
0.001 ± 
0.002 
0.005 ± 
0.003 
(4)  Flavone  400 µM  >400 µM  50 sec  9+ min 
0.292 ± 
0.144 
0.412 ± 
0.076 
 (5)  Flavone  200 µM  350 µM  1.50 min  1.56 min 
0.050 ± 
0.011* 
0.399 ± 
0.010 
 (6)  Lignan  100 µM  100 µM  24 sec  1.06 min 
0.000 ± 
0.000 
0.003 ± 
0.002 
 (7)  Alkaloid  400 µM  400 µM  1.06 min  1.15 min 
0.002 ± 
0.001 
0.000 ± 
0.001 
(8)  Flavonol  >400 µM  >400 µM  1.10 min  1.20 min 
0.008 ± 
0.000 
0.008 ± 
0.002 
(9)  Flavanone  >400 µM  >400 µM  37 sec  1.05 min 
0.000 ± 
0.000 
0.001 ± 
0.002 
 (10)  Alkaloid  >400 µM  >400 µM  51 sec  1.1 min 
0.000 ± 
0.000 
0.001 ± 
0.002 
(11)  Alkaloid  >400 µM  >400 µM  35 sec  40 sec 
0.003 ± 
0.001 
0.004 ± 
0.004 
(12)  Alkaloid  >400 µM  >400 µM  9+ min  9+ min 
0.056 ± 
0.018 
0.021 ± 
0.006 
 (13)  Flavone  >400 µM  >400 µM  9+ min  9+ min 
0.418 ± 
0.018* 
0.102 ± 
0.008 
 (14)  Isoprene  >400 µM  >400 µM  3.50 min  9+ min 
0.360 ± 
0.063 
0.479 ± 
0.025 
 (15) B 
Dimeric 
naphthoquinone 
>100 µM  >100 µM  9+ min  9+ min 
0.056 ± 
0.010* 
0.243 ± 
0.006 
(16)  Anthocyanidin  >400 µM  >400 µM  30 sec  33 sec 
0.015 ± 
0.000* 
0.035 ± 
0.003 
(17)  Anthroquinone  >400 µM  >400 µM  2.02 min  2.35 min 
0.326 ± 
0.064* 
0.467 ± 
0.015 
(18)  Iridoid  >400 µM  >400 µM  35 sec  34 sec 
0.002 ± 
0.001* 
0.007 ± 
0.002 
 (19)  Steroid  >400 µM  >400 µM  9+ min  9+ min 
0.019 ± 
0.002 
0.033 ± 
0.010 
 (20)*  Statin  >400 µM  >400 µM  1.07 min  2.10 min 
0.072 ± 
0.027 
0.010 ± 
0.003 
(21)  Xanthone  6 µM  12 µM  1.17 min  5.50 min 
0.056 ± 
0.008 
0.052 ± 
0.004 
*	‐Statistically	significant	difference	in	OD600 between	DMSO/water	and	
DMSO/glycerol	at	the	90th	percentile	
A	‐	Müeller‐Hinton	broth	included	
B	–	Aurofusarin	was	tested	at	100	µM	due	to	limited	supply
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Figure	2.5.	Comparison	of	Aurofusarin	in	Solvents.		–	Aurofusarin	standard	
dissolved	in	glycerol/DMSO	(left)	and	water/DMSO	(right).		
	
	
2.2.2.	Spectrophotometric	Method	to	Compare	Solubility	
We	evaluated	the	effectiveness	of	a	spectrophotometric	method	to	compare	
the	solubility	of	each	compound	in	the	two	solvent	systems.		Particulate	matter	(due	
to	poor	solubility)	should	cause	light	scattering,	and	lead	to	an	apparent	increase	in	
absorbance	at	600	nm	(OD600).			
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Figure	2.6.	Solubility	Analysis	of	Enoxolone.	As	concentration	increased,	we	
see	an	increase	in	absorbance	for	the	DMSO/water	solvent	indicating	poor	
solubility.	
	
	
	One	such	example	is	shown	in	Figure	2.6,	where	the	2%	DMSO/water	
solution	of	enoxolone	resulted	in	absorbance	readings	that	were	significantly	higher	
than	that	of	the	same	concentrations	dissolved	in	2%	DMSO/glycerol.	We	attribute	
these	high	readings	to	the	compound	crashing	out	of	solution,	thus	partially	
blocking	some	light	resulting	in	a	higher	absorbance	reading.	We	chose	to	record	
absorbance	values	at	the	highest	concentration	in	Table	2.1	as	this	point	tended	to	
vary	the	most	and	would	allow	for	an	easy	comparison	in	solvent	composition.	
Absorption	data	comparison	at	the	highest	concentration	tested	(400µM)	revealed	
the	general	trend	that	the	glycerol/DMSO	combination	improved	the	solubility	of	six	
(2,	5,	15,	16,	17,	18)	of	the	compounds	and	reduced	solubility	for	three	compounds	
(1,	13,	20).	
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One	potential	downside	of	using	a	spectrophotometric	approach	to	compare	
solubility	is	the	chance	of	potential	false	positives.	It	is	important	to	note	the	non‐
linear	form	of	the	absorbance	for	the	compound	crashing	out	in	the	solubility	graph	
(Figure	2.6).	It	is	possible	that	linear	increases	in	absorbance	versus	concentration	
could	occur	not	because	of	particulate	matter	in	the	solution,	but	due	to	actual	
absorbance	of	light	by	the	compound	under	investigation.		This	would	be	true	if	the	
compound	absorbs	light	at	600	nm.				
	
	
Figure	2.7.	Solubility	Analysis	of	Quinalizarin.	Both	solvent	compositions	
resulted	in	a	linear	increase	with	respect	to	concentration.	We	theorize	the	
compound	is	absorbing	the	light	and	following	Beer’s	law.	
	
Quinalizarin	was	one	compound	tested	that	we	hypothesize	gives	a	false	
solubility	reading	due	to	light	absorbance	(Figure	2.7).		Quinalizarin	has	a	deep	red	
color,	and	absorbs	in	the	600	nm	range	(Figure	2.8).	Thus,	the	data	suggesting	
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solubility	issues	with	this	compound	(Figure	2.7)	are	suspect.	In	order	to	minimize	
false	reports	in	our	absorbance	analysis,	readings	from	~260	to	800	nm	were	
collected	at	400µM	for	each	solvent	condition	to	ensure	there	was	no	evident	peak	
at	or	near	600	nm.	A	peak	here	could	cause	higher	absorbance	readings	which	could	
be	misconstrued	to	be	a	poorly	soluble	compound	such	as	with	quinalizarin.	In	most	
cases	however	(for	example,	enoxolone	in	Figure	2.9),	no	absorbance	peak	at	600	
nm	was	observed.		
	
Figure	2.8.	Quinalizarin	Absorbance	Spectrum.	DMSO/glycerol/media	left	and	
DMSO/water/media	right	–	a	small	increase	in	absorbance	is	found	near	600	nm	
where	plates	are	read.	
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Figure	2.9.	Enoxolone	Absorbance	Spectrum.	DMSO/glycerol/media	left	and	
DMSO/water/media	right	–	no	peaks	were	found	near	the	600	nm	region.	
	
	
2.2.3.	Comparison	of	Solubility	with	LC‐MS	
To	confirm	that	our	spectrophotometric	approach	of	testing	solubility	was	
effective,	standard	practice	of	filtering	the	samples	and	subjecting	them	to	LC‐MS	to	
compare	overall	peak	areas	of	each	compound	in	solution	was	conducted.		
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Figure	2.10.	LC‐MS	Selected	Ion	Chromatogram	of	Enoxolone.		DMSO/glycerol	
(top)	and	DMSO/water	(bottom)	at	400µM.	The	DMSO/glycerol	peak	area	was	7.8	
times	larger	than	that	of	the	DMSO/water,	indicating	the	compound	was	more	
soluble	in	the	glycerol	solution.	
	
	
In	the	case	of	enoxolone	(Figure	2.10),	the	DMSO/water	absorbance	was	
higher	than	that	of	the	DMSO/glycerol	solution	(0.506	vs	0.039	respectively)	(Table	
2.1).	The	high	absorbance	well	readings	are	a	direct	result	of	insoluble	compound.	
The	insoluble	portions	were	then	filtered	off	and	the	filtrate	was	compared	using	
LC‐MS.	The	peak	areas	of	these	same	wells	show	that	enoxolone	is	more	
concentrated	in	the	DMSO/glycerol	solution,	as	the	compound	was	in	solution	and	
not	crashed	out.	These	results	are	comparable	to	the	spectrophotometric	results	for	
enoxolone	and	select	compounds	tested	in	Table	2.2.		
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Table	2.2	LC‐MS	Selected	Ion	Chromatogram	Peak	Area	Comparisons	with	
Standard	Error	
Compound	
(400µM)	
Glycerol/DMSO	Peak	
Area	
Water/DMSO	Peak	
Area	
Analogous	
Results	to	
Spectral	
Data	
Apigenin	 1.12	x	10
7	±	2.79	x	105
	
1.18	x	107	±	2.13	x	105	
	
Yes	
Magnolol	 2.22	x	10
7	±	2.82	x	106	
	
1.85	x	107	±	3.57	x	106	
	
Yes	
Anisodamine	 1.69	x	10
10	±	7.83	x	108
	
1.89	x	1010	±	2.65	x	
108	
Yes	
Simvastatin*	 2.47	x	10
7	±	7.28	x	105
	
4.53	x	107	±	1.98	x	106	
	
Yes	
Enoxolone*	 1.76	x	10
9	±	4.39	x	107	
	
2.07	x	108	±	3.85	x	106	
	
Yes	
Aurofusarina*	
	
7.62E	x	105	±	2.83	x	104
	
5.08	x	105	±	3.84	x	104	
	
Yes	
*Statistically	significant	difference	between	peak	areas	in	the	two	solvents	at	the	
90th	percent	confidence	interval	based	on	student’s	t‐test.		
a‐	Tested	at	100	µM	due	to	supply	
	
	
These	parallel	results	confirm	that	our	spectrophotometric	readings	are	a	
viable	way	of	determining	solubility	of	compounds	in	our	assay.	One	potential	
downside	of	LC‐MS	verification	of	solubility	as	opposed	to	spectrophotometric	
studies	is	the	requirement	that	your	compound	is	ionizable.	We	expected	
quinalizarin	would	have	had	a	slight	difference	in	peak	areas	between	solvents	but	
were	unable	to	ionize	with	electrospray	ionization	(ESI).	Compounds	that	don’t	
ionize	well	with	standard	ESI	practices	require	different	sources	and	method	
development	which	could	hinder	high	throughput	screenings.	Additionally,	reading	
with	a	plate	reader	takes	approximately	30	seconds	as	compared	to	a	10	minute	LC	
method	required	for	separation	using	MS.	
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2.3	Antimicrobial	Testing		
	 Antimicrobial	activity	was	evaluated	against	S.	aureus	with	all	of	the	
compounds	in	Table	2.1	in	both	a	DMSO/glycerol/broth	and	DMSO/water/broth	
solution.	We	expected	that	with	improved	solubility	of	the	compounds,	we	would	
observe	enhanced	activity	of	bioactive	compounds	against	the	bacteria.	
	
	
Figure	2.11.	Minimum	Inhibitory	Concentration	Studies	of	Enoxolone.	We	
demonstrate	that	with	poor	solubility	in	water/DMSO,	no	activity	was	found	for	
the	compound.	When	solubilized	with	glycerol/DMSO,	we	see	a	standard	MIC	
curve	with	a	reported	MIC	of	250	µM.	
	
	
	Using	enoxolone	as	an	example	(Figure	2.11),	no	activity	was	observed	for	the	
DMSO/water	solution	of	the	compound	as	indicated	by	the	flat	line	of	bacteria	
optical	density.	Without	solubility	testing,	one	would	mistakenly	report	this	
compound	as	inactive.	By	contrast,	the	DMSO/glycerol	solution	demonstrated	a	
standard	minimum	inhibitory	concentration	(MIC)	of	250	µM	proving	the	
compound	is	bioactive.	Our	studies	found	that	of	the	bioactive	compounds,	
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DMSO/glycerol	improved	the	ability	to	observe	biological	activity	(i.e.	reduced	MIC	
values)	for	4	(2,	4,	5,	6)	out	the	7	active	compounds.
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CHAPTER	III	
	
EXPERIMENTAL	
	
	
3.1	Standard	Preparation		
	 Standards	were	ordered	from	from	Sigma	Aldrich	(3,	7,	8,	9,	10,	11,	12,	13,	
16,	17,	18,	19,	20,	21),	Selleckchem	(1,	2,	4,	5,	6),	Acros‐organics	(14),	Bioviotica	
(15)	and	were	suspended	to	10	mM	using	either	50/50	(v/v)	DMSO/glycerol	(Fisher	
Scientific)	or	DMSO/nanopure	water	in	vials.	A	timer	was	then	started	and	the	
standards	were	vortexed	first	to	see	if	the	compound	would	easily	dissolve.	In	the	
event	of	poor	solubility,	the	compounds	were	placed	in	sonicator	to	break	up	
clumps,	then	a	hot	water	bath	for	a	short	period	and	vortexed	again.	After	
solubilizing	to	the	best	of	our	ability,	serial	2‐fold	dilutions	were	performed	from	10	
mM	to	0.78	µM	for	each	standard.	
3.2	Antimicrobial	Testing	 	
	 Overnight	seed	cultures	were	diluted	1:3	with	Müeller‐Hinton	broth	and	
shaken	for	2	hours	at	300	rpm.	An	additional	dilution	to	normalize	the	colony	
forming	units	(CFU)	for	each	plate	was	performed	to	give	a	final	dilution	of	1.0	x	105	
CFU/ml	based	on	OD600	of	0.118	S.	aureus	after	the	2	hours	of	shaking.	Evaluation	of	
antimicrobial	testing	was	performed	utilizing	a	96‐well	sample	plate	setup	in	which	
10	uL	of	each	compound	was	transferred	into	a	well	containing	190	uL	of	broth	and	
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50	uL	of	bacteria	(SA1199	Staphylococcus	aureus).	Final	concentrations	of	
compound	ranged	from	400	µM	to	3µM	in	triplicate.	The	plates	were	then	shaken	at	
1000	rpm	at	37	˚C	in	a	Stuart	S1505	microtitre	plate	shaker	for	at	least	18	hours.	
Following	incubation,	plates	were	read	using	a	Synergy	H1	Mutli‐Mode	Reader	at	
600	nm	to	obtain	absorption	spectra.	A	blank	plate’s	optical	density	readings	
containing	no	bacteria	(240	uL	broth	and	10	uL	compound)	was	then	subtracted	
from	the	sample	plate	to	give	the	OD600	of	the	bacteria	alone.		
3.3	Solubility	Analysis	
	 Using	the	blank	plate,	solubility	of	each	well	concentration	(400µM	to	3µM)	
was	evaluated	by	subtracting	out	the	absorbance	values	of	a	2%	DMSO/glycerol	or	
2%	DMSO/water	control	to	find	the	absorbance	value	of	the	compound	in	question.	
These	OD600	values	were	then	plotted	against	concentration	for	comparison	of	
solvents.	The	blank	plate	was	also	analyzed	at	400	µM	across	multiple	wavelengths	
from	280	nm	to	800	nm	to	determine	if	there	was	an	observable	absorbance	peak	
near	the	600	nm	range.	The	400	µM	wells	were	then	vacuum	filtered	and	analyzed	
via	LC‐MS	(CH3CN/H2O	(with	0.1%	formic	acid)	15‐100%	CH3CN	over	10	minutes)	
using	a	Q	Exactive	Plus	Hybrid	Quadropole‐Orbitrap	coupled	to	an	Acuity	ultra‐high	
performance	liquid	chromatography	(UPLC)	system.	Selected	ion	chromatograms	
for	each	compound	were	then	compared.
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CHAPTER	IV	
	
CONCLUSION	
	
	
In	conclusion,	this	project	was	developed	in	order	to	quickly	assess	
compound	solubility	within	our	bioassays	as	well	as	improve	solubility	with	trouble	
compounds	with	the	addition	of	glycerol	as	a	co‐solvent.	Our	studies	found	glycerol	
was	suitable	co‐solvent	with	DMSO	for	improving	solubility	in	bioassay	screenings	
of	S.	aureus.		It	also	found	of	the	21	compounds	tested,	10	which	showed	
improvement	in	the	time	it	took	to	solubilize,	6	showed	solubility	enhancements	in	
bioassays,	and	4	showed	improvements	in	MICs.	These	findings	show	we	now	have	
a	rapid	way	to	assess	our	solubility	and	offer	a	novel	solution	to	solubility	problems	
which	may	arise.
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